Document is current
Any future updates will be listed below
-
Authors
Malley, Brian E.
Yabes, Jonathan G.
Gimbel, Elizabeth
Chang, Chung-Chou H.
Yealy, Donald M.
Fine, Michael J.
Angus, Derek C.
Huang, David T. https://orcid.org/0000-0001-7649-1633
,
Doi, Yohei
Eaton, Tammy L.
Fine, Michael J.
Gimbel, Elizabeth A.
Peck Palmer, Octavia M.
Pike, Francis
Ryman, Ashley M.
Weissfeld, Lisa A.
Wofford, Kourtney A.
Xu, Tianyuan
Yabes, Jonathan G.
Donnino, Michael W.
Aisiku, Imoigele P.
Hou, Peter C.
Seethala, Raghu R.
Sherwin, Robert L.
Holst, John M.
Fischer, Michelle A.
Rafferty, Colleen M.
Dachman, William D.
LoVecchio, Frank
Filbin, Michael R.
Mansour, Michael K.
Fine, Jonathan M.
Hammel, Jean M.
Exline, Matthew J.
Southerland, Lauren T.
Terndrup, Thomas E.
Kurz, Michael C.
McCullum, David L.
Wang, Henry E.
Amin, Alpesh N.
Lotfipour, Shahram
Khan, Feras H.
Gentry Wilkerson, R.
Prunty, Heather A.
Suffoletto, Brian
Brown, Aaron M.
Jovin, Franziska F.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02130986 at ClinicalTrials.govDocuments that mention this clinical trial
Impact of adherence to procalcitonin antibiotic prescribing guideline recommendations for low procalcitonin levels on antibiotic use
https://doi.org/10.1186/s12879-022-07923-0
-
Funding
Funding for this research was provided by:
National Institute of General Medical Sciences (1R34GM102696-01, 1R01GM101197-01A1)
- License Information
-
More Information
Article History
Received: 11 June 2022
Accepted: 5 December 2022
First Online: 19 January 2023
Declarations
:
: The study was approved by the University of Pittsburgh Institutional Review Board. Informed consent was obtained for all participants in the ProACT trial.
: Not applicable.
: The authors have no competing interests to declare.
